![]()
Source:Archives of Physical Medicine and Rehabilitation, Volume 99, Issue 4
https://ift.tt/2EdEUGG
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Publication date: April 2018
Source:Archives of Physical Medicine and Rehabilitation, Volume 99, Issue 4
Author(s): Ettore Beghi, Elisa Gervasoni, Elisabetta Pupillo, Elisa Bianchi, Angelo Montesano, Irene Aprile, Michela Agostini, Marco Rovaris, Davide Cattaneo
ObjectiveTo compare the risk of falls and fall predictors in patients with Parkinson disease (PD), multiple sclerosis (MS), and stroke using the same study design.DesignMulticenter prospective cohort study.SettingInstitutions for physical therapy and rehabilitation.ParticipantsPatients (N=299) with PD (n=94), MS (n=111), and stroke (n=94) seen for rehabilitation.InterventionsNot applicable.Main Outcome MeasuresFunctional scales were applied to investigate balance, disability, daily performance, self-confidence with balance, and social integration. Patients were followed for 6 months. Telephone interviews were organized at 2, 4, and 6 months to record falls and fall-related injuries. Incidence ratios, Kaplan-Meier survival curves, and Cox proportional hazards models were used.ResultsOf the 299 patients enrolled, 259 had complete follow-up. One hundred and twenty-two patients (47.1%) fell at least once; 82 (31.7%) were recurrent fallers and 44 (17.0%) suffered injuries; and 16%, 32%, and 40% fell at 2, 4, and 6 months. Risk of falls was associated with disease type (PD, MS, and stroke in decreasing order) and confidence with balance (Activities-specific Balance Confidence [ABC] scale). Recurrent fallers were 7%, 15%, and 24% at 2, 4, and 6 months. The risk of recurrent falls was associated with disease type, high educational level, and ABC score. Injured fallers were 3%, 8%, and 12% at 2, 4, and 6 months. The only predictor of falls with injuries was disease type (PD).ConclusionsPD, MS, and stroke carry a high risk of falls. Other predictors include perceived balance confidence and high educational level.
https://ift.tt/2IjLgXl
![]()
![]()
![]()


Publication date: Available online 2 April 2018
Source:European Journal of Vascular and Endovascular Surgery
Author(s): Bruno Migliara, Tania F. Cappellari
https://ift.tt/2H44Uad
Publication date: Available online 2 April 2018
Source:European Journal of Vascular and Endovascular Surgery
Author(s): Mohammed M. Chowdhury, James H.F. Rudd, Patrick A. Coughlin
https://ift.tt/2GwHiu1
Publication date: Available online 2 April 2018
Source:Cell Metabolism
Author(s): Camila Rubio-Patiño, Jozef P. Bossowski, Gian Marco De Donatis, Laura Mondragón, Elodie Villa, Lazaro E. Aira, Johanna Chiche, Rana Mhaidly, Cynthia Lebeaupin, Sandrine Marchetti, Konstantinos Voutetakis, Aristotelis Chatziioannou, Florence A. Castelli, Patricia Lamourette, Emeline Chu-Van, François Fenaille, Tony Avril, Thierry Passeron, John B. Patterson, Els Verhoeyen, Béatrice Bailly-Maitre, Eric Chevet, Jean-Ehrland Ricci
Dietary restriction (DR) was shown to impact on tumor growth with very variable effects depending on the cancer type. However, how DR limits cancer progression remains largely unknown. Here, we demonstrate that feeding mice a low-protein (Low PROT) isocaloric diet but not a low-carbohydrate (Low CHO) diet reduced tumor growth in three independent mouse cancer models. Surprisingly, this effect relies on anticancer immunosurveillance, as depleting CD8+ T cells, antigen-presenting cells (APCs), or using immunodeficient mice prevented the beneficial effect of the diet. Mechanistically, we established that a Low PROT diet induces the unfolded protein response (UPR) in tumor cells through the activation of IRE1α and RIG1 signaling, thereby resulting in cytokine production and mounting an efficient anticancer immune response. Collectively, our data suggest that a Low PROT diet induces an IRE1α-dependent UPR in cancer cells, enhancing a CD8-mediated T cell response against tumors.
@media screen and (max-width:400px) { .two .column, .two .left, .two .right{ max-width: 100% !important; } } @media screen and (min-width: 401px) and (max-width:620px){ .two .column, .two .left, .two .right { max-width: 100% !important; } }
|
Journal of Cosmetic Dermatology, EarlyView.
https://ift.tt/2pW6CmG